• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管系统中的蛋白激酶D:在健康与疾病中的新作用

Protein kinase d in the cardiovascular system: emerging roles in health and disease.

作者信息

Avkiran Metin, Rowland Alexandra J, Cuello Friederike, Haworth Robert S

机构信息

Cardiovascular Division, King's College London, The Rayne Institute, St Thomas' Hospital, London SE1 7EH, United Kingdom.

出版信息

Circ Res. 2008 Feb 1;102(2):157-63. doi: 10.1161/CIRCRESAHA.107.168211.

DOI:10.1161/CIRCRESAHA.107.168211
PMID:18239146
Abstract

The protein kinase D (PKD) family is a recent addition to the calcium/calmodulin-dependent protein kinase group of serine/threonine kinases, within the protein kinase complement of the mammalian genome. Relative to their alphabetically superior cousins in the AGC group of kinases, namely the various isoforms of protein kinase A, protein kinase B/Akt, and protein kinase C, PKD family members have to date received limited attention from cardiovascular investigators. Nevertheless, increasing evidence now points toward important roles for PKD-mediated signaling pathways in the cardiovascular system, particularly in the regulation of myocardial contraction, hypertrophy and remodeling. This review provides a primer on PKD signaling, using information gained from studies in multiple cell types, and discusses recent data that suggest novel functions for PKD-mediated pathways in the heart and the circulation.

摘要

蛋白激酶D(PKD)家族是哺乳动物基因组蛋白激酶补充体系中,丝氨酸/苏氨酸激酶的钙/钙调蛋白依赖性蛋白激酶组中的新成员。相对于激酶AGC组中按字母顺序排在前面的同类蛋白,即蛋白激酶A、蛋白激酶B/Akt和蛋白激酶C的各种亚型,PKD家族成员迄今为止受到心血管研究人员的关注有限。然而,越来越多的证据表明PKD介导的信号通路在心血管系统中发挥重要作用,尤其是在心肌收缩、肥大和重塑的调节方面。本综述利用从多种细胞类型研究中获得的信息,对PKD信号传导进行了初步介绍,并讨论了近期数据,这些数据表明PKD介导的通路在心脏和循环系统中具有新功能。

相似文献

1
Protein kinase d in the cardiovascular system: emerging roles in health and disease.心血管系统中的蛋白激酶D:在健康与疾病中的新作用
Circ Res. 2008 Feb 1;102(2):157-63. doi: 10.1161/CIRCRESAHA.107.168211.
2
Protein kinase D signaling in cancer: A friend or foe?蛋白激酶 D 信号通路与癌症:是敌是友?
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):283-294. doi: 10.1016/j.bbcan.2017.05.008. Epub 2017 May 31.
3
Derepression of pathological cardiac genes by members of the CaM kinase superfamily.钙调蛋白激酶超家族成员对病理性心脏基因的去抑制作用。
Cardiovasc Res. 2007 Mar 1;73(4):667-77. doi: 10.1016/j.cardiores.2006.11.036. Epub 2006 Dec 5.
4
Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK.鉴定蛋白激酶D为一种与GLUT4介导的葡萄糖摄取相关的新型收缩激活激酶,独立于AMPK。
Cell Signal. 2008 Mar;20(3):543-56. doi: 10.1016/j.cellsig.2007.11.007. Epub 2007 Nov 26.
5
Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation.心肌中蛋白激酶D/蛋白激酶Cμ的表达与活性:α1-肾上腺素能受体和蛋白激酶C介导调控的证据
J Mol Cell Cardiol. 2000 Jun;32(6):1013-23. doi: 10.1006/jmcc.2000.1143.
6
Role of protein kinase D signaling in pancreatic cancer.蛋白激酶 D 信号通路在胰腺癌中的作用。
Biochem Pharmacol. 2010 Dec 15;80(12):1946-54. doi: 10.1016/j.bcp.2010.07.002. Epub 2010 Jul 16.
7
Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation.磷酸二酯酶同工型对蛋白激酶 A 介导的心肌蛋白激酶 D 激活衰减的调节。
Basic Res Cardiol. 2011 Jan;106(1):51-63. doi: 10.1007/s00395-010-0116-1. Epub 2010 Aug 20.
8
Protein kinase D in vascular biology and angiogenesis.蛋白激酶 D 在血管生物学和血管生成中的作用。
IUBMB Life. 2011 Apr;63(4):258-63. doi: 10.1002/iub.456.
9
AKAP13 Rho-GEF and PKD-binding domain deficient mice develop normally but have an abnormal response to β-adrenergic-induced cardiac hypertrophy.AKAP13 Rho-GEF 和 PKD 结合域缺失小鼠发育正常,但对 β-肾上腺素能诱导的心脏肥大反应异常。
PLoS One. 2013 Apr 26;8(4):e62705. doi: 10.1371/journal.pone.0062705. Print 2013.
10
PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway.多囊肾病基因敲低通过AKT/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路促进自噬,从而抑制压力超负荷诱导的心肌肥大。
Int J Biol Sci. 2017 Feb 12;13(3):276-285. doi: 10.7150/ijbs.17617. eCollection 2017.

引用本文的文献

1
Extracellular glucose and dysfunctional insulin receptor signaling independently upregulate arterial smooth muscle TMEM16A expression.细胞外葡萄糖和功能失调的胰岛素受体信号独立地上调动脉平滑肌 TMEM16A 的表达。
Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1237-C1247. doi: 10.1152/ajpcell.00555.2023. Epub 2024 Mar 4.
2
Protein Kinase D Plays a Crucial Role in Maintaining Cardiac Homeostasis by Regulating Post-Translational Modifications of Myofilament Proteins.蛋白激酶D通过调节肌丝蛋白的翻译后修饰在维持心脏稳态中起关键作用。
Int J Mol Sci. 2024 Feb 28;25(5):2790. doi: 10.3390/ijms25052790.
3
Protein Kinase D1 Regulates Cardiac Hypertrophy, Potassium Channel Remodeling, and Arrhythmias in Heart Failure.
蛋白激酶 D1 调控心力衰竭中的心肌肥厚、钾通道重构和心律失常。
J Am Heart Assoc. 2022 Oct 4;11(19):e027573. doi: 10.1161/JAHA.122.027573. Epub 2022 Sep 29.
4
Identification of Phosphorylation and Other Post-Translational Modifications in the Central C4C5 Domains of Murine Cardiac Myosin Binding Protein C.小鼠心肌肌球蛋白结合蛋白C中央C4C5结构域中磷酸化及其他翻译后修饰的鉴定
ACS Omega. 2022 Apr 18;7(16):14189-14202. doi: 10.1021/acsomega.2c00799. eCollection 2022 Apr 26.
5
Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy.靶向蛋白激酶D的小分子抑制剂:一种潜在的治疗策略。
Front Oncol. 2021 Jun 24;11:680221. doi: 10.3389/fonc.2021.680221. eCollection 2021.
6
Novel Autosomal Recessive Splice-Altering Variant in Is Associated with Congenital Heart Disease.新型常染色体隐性剪接变异与先天性心脏病相关。
Genes (Basel). 2021 Apr 21;12(5):612. doi: 10.3390/genes12050612.
7
Metabolic Interventions to Prevent Hypertrophy-Induced Alterations in Contractile Properties In Vitro.代谢干预防止体外肥大诱导的收缩性能改变。
Int J Mol Sci. 2021 Mar 31;22(7):3620. doi: 10.3390/ijms22073620.
8
Activation of Tripartite Motif Containing 63 Expression by Transcription Factor EB and Transcription Factor Binding to Immunoglobulin Heavy Chain Enhancer 3 Is Regulated by Protein Kinase D and Class IIa Histone Deacetylases.转录因子EB和转录因子与免疫球蛋白重链增强子3的结合对含63个三联基序的蛋白表达的激活受蛋白激酶D和IIa类组蛋白去乙酰化酶调控。
Front Physiol. 2021 Jan 13;11:550506. doi: 10.3389/fphys.2020.550506. eCollection 2020.
9
Phosphatidylinositol 4-kinase IIIβ mediates contraction-induced GLUT4 translocation and shows its anti-diabetic action in cardiomyocytes.磷脂酰肌醇 4-激酶 IIIβ 介导收缩诱导的 GLUT4 易位,并在心肌细胞中表现出其抗糖尿病作用。
Cell Mol Life Sci. 2021 Mar;78(6):2839-2856. doi: 10.1007/s00018-020-03669-7. Epub 2020 Oct 22.
10
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D.通过蛋白激酶D调节肥厚型心肌病中基于肌联蛋白的僵硬度
Front Physiol. 2020 Apr 15;11:240. doi: 10.3389/fphys.2020.00240. eCollection 2020.